Wen‐Shan Li

2.7k total citations
81 papers, 2.2k citations indexed

About

Wen‐Shan Li is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Wen‐Shan Li has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Wen‐Shan Li's work include Glycosylation and Glycoproteins Research (13 papers), Peptidase Inhibition and Analysis (13 papers) and Cancer therapeutics and mechanisms (7 papers). Wen‐Shan Li is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Peptidase Inhibition and Analysis (13 papers) and Cancer therapeutics and mechanisms (7 papers). Wen‐Shan Li collaborates with scholars based in Taiwan, United States and China. Wen‐Shan Li's co-authors include Frank M. Raushel, Chie‐Hong Wang, Wen‐Chun Hung, Shivaji V. More, Lawrence M. Sayre, Shu‐Chuan Jao, Craig Hill, Shiyong Zhao, Chang Liu and Peng‐Xiang Hou and has published in prestigious journals such as Journal of the American Chemical Society, ACS Nano and PLoS ONE.

In The Last Decade

Wen‐Shan Li

79 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Shan Li Taiwan 28 817 634 419 318 274 81 2.2k
Kelin Li United States 28 1.0k 1.3× 808 1.3× 438 1.0× 156 0.5× 192 0.7× 95 2.7k
Guoying Chen China 32 1.9k 2.4× 903 1.4× 618 1.5× 385 1.2× 316 1.2× 140 4.4k
Zhenjiang Liu China 29 719 0.9× 800 1.3× 856 2.0× 256 0.8× 477 1.7× 170 3.1k
Pietro Vidossich Spain 25 770 0.9× 799 1.3× 377 0.9× 136 0.4× 141 0.5× 73 2.3k
Qin Xu China 23 982 1.2× 416 0.7× 255 0.6× 130 0.4× 68 0.2× 103 1.9k
Michael F. Rohde United States 33 1.4k 1.8× 355 0.6× 298 0.7× 156 0.5× 61 0.2× 86 3.1k
Cristina Núñez Spain 30 738 0.9× 295 0.5× 865 2.1× 253 0.8× 144 0.5× 96 2.5k
Zbigniew Szewczuk Poland 26 1.4k 1.7× 286 0.5× 174 0.4× 346 1.1× 93 0.3× 167 2.6k
S. Kamitori Japan 33 1.5k 1.8× 642 1.0× 602 1.4× 180 0.6× 117 0.4× 120 3.1k

Countries citing papers authored by Wen‐Shan Li

Since Specialization
Citations

This map shows the geographic impact of Wen‐Shan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Shan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Shan Li more than expected).

Fields of papers citing papers by Wen‐Shan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Shan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Shan Li. The network helps show where Wen‐Shan Li may publish in the future.

Co-authorship network of co-authors of Wen‐Shan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Shan Li. A scholar is included among the top collaborators of Wen‐Shan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Shan Li. Wen‐Shan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Wei‐Sheng, et al.. (2025). Optimizing ST6GAL1 inhibition and selectivity using lithocholic acid-amino acid conjugates for antimetastatic and antiangiogenic agent development. Bioorganic Chemistry. 159. 108401–108401. 2 indexed citations
3.
Hsiao, Pei‐Wen, et al.. (2024). Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis. International Journal of Molecular Sciences. 25(8). 4283–4283. 6 indexed citations
4.
Lu, Ruei‐Min, Monika Kumari, Guanhong Chen, et al.. (2024). Current landscape of mRNA technologies and delivery systems for new modality therapeutics. Journal of Biomedical Science. 31(1). 89–89. 34 indexed citations
5.
6.
Luca, Roberto De, Chi‐Hung Huang, Yu‐Chen S. H. Yang, et al.. (2022). Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition. Food and Chemical Toxicology. 161. 112850–112850. 10 indexed citations
7.
Chen, Chia‐Ling, et al.. (2021). Design, synthesis, and characterization of oxadiazolopyrazine analogs with application as anticancer agents. Journal of the Chinese Chemical Society. 69(2). 375–387. 1 indexed citations
8.
Tan, Yanbin, et al.. (2019). Primary thoracic neuroblastoma in an adult. Medicine. 98(30). e16564–e16564. 3 indexed citations
9.
Chen, Chia‐Ling, Alagarsamy Mathavan, Arumugam Ramdass, et al.. (2018). Aggregation‐induced emission enhancement of anthracene‐derived Schiff base compounds and their application as a sensor for bovine serum albumin and optical cell imaging. Luminescence. 33(4). 780–789. 48 indexed citations
10.
Nana, André Wendindondé, Szu‐Yuan Wu, Yu‐Chen S. H. Yang, et al.. (2018). Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers. Hormones and Cancer. 9(5). 349–360. 22 indexed citations
11.
Abdu-Allah, Hajjaj H.M., et al.. (2016). Nature-inspired design of tetraindoles: Optimization of the core structure and evaluation of structure–activity relationship. Bioorganic & Medicinal Chemistry Letters. 26(18). 4497–4503. 2 indexed citations
12.
Chiang, Chih-Po, et al.. (2014). Inhibition of Chemokine (C-C Motif) Receptor 7 Sialylation Suppresses CCL19-Stimulated Proliferation, Invasion and Anti-Anoikis. PLoS ONE. 9(6). e98823–e98823. 28 indexed citations
13.
Li, Shisheng, Peng‐Xiang Hou, Chang Liu, et al.. (2014). Honeycomb-like single-wall carbon nanotube networks. Journal of Materials Chemistry A. 2(10). 3308–3311. 2 indexed citations
14.
Wang, Chie‐Hong, Chia‐Ling Chen, Shivaji V. More, et al.. (2014). The Tetraindole SK228 Reverses the Epithelial-to-Mesenchymal Transition of Breast Cancer Cells by Up-Regulating Members of the miR-200 Family. PLoS ONE. 9(6). e101088–e101088. 10 indexed citations
15.
Chen, Jia-Yang, Yen-An Tang, Hsueh‐Fen Juan, et al.. (2011). A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways. Cancer Research. 71(2). 473–483. 115 indexed citations
16.
Chen, Mei‐Yu, et al.. (2011). The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. International Journal of Cancer. 131(3). 722–732. 28 indexed citations
17.
More, Shivaji V., et al.. (2011). Polyfluorinated bipyridine cisplatins manipulate cytotoxicity through the induction of S-G2/M arrest and partial intercalation mechanism. Bioorganic & Medicinal Chemistry. 19(16). 4887–4894. 16 indexed citations
18.
Hsu, Yu‐Ting, et al.. (2008). Evaluation of Organophosphorus Chemicals‐Degrading Enzymes: A Comparison of Escherichia coli and Human Cytosolic Aminopeptidase P. Chemistry & Biodiversity. 5(7). 1401–1411. 6 indexed citations
19.
Jao, Shu‐Chuan, et al.. (2005). Design of potent inhibitors for Schistosoma japonica glutathione S-transferase. Bioorganic & Medicinal Chemistry. 14(2). 304–318. 17 indexed citations
20.
Li, Wen‐Shan, et al.. (2001). Stereoselective Detoxification of Chiral Sarin and Soman Analogues by Phosphotriesterase. Bioorganic & Medicinal Chemistry. 9(8). 2083–2091. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelin Li Breakdown of academic impact, for papers by Guoying Chen Breakdown of academic impact, for papers by Zhenjiang Liu Breakdown of academic impact, for papers by Pietro Vidossich Breakdown of academic impact, for papers by Qin Xu Breakdown of academic impact, for papers by Michael F. Rohde Breakdown of academic impact, for papers by Cristina Núñez Breakdown of academic impact, for papers by Zbigniew Szewczuk Breakdown of academic impact, for papers by S. Kamitori
Rankless by CCL
2026